Document is current
Any future updates will be listed below
-
Authors
Quiros-Roldan, Eugenia
Magro, Paola http://orcid.org/0000-0001-7660-161X
Carriero, Canio
Chiesa, Annacarla
El Hamad, Issa
Tratta, Elena
Fazio, Raffaella
Formenti, Beatrice
Castelli, Francesco
- License Information
-
More Information
Article History
Received: 29 June 2020
Accepted: 29 August 2020
First Online: 4 October 2020
Competing interests
: FC reports acting as a principle investigator of company-sponsored clinical trials in the field of HIV infection (ViiV Healthcare, GlaxoSmithKline, Gilead Sciences and Janssen – Cilag). EQR. received travel grants from Bristol-Myers Squibb, Gilead Sciences, ViiV Healthcare, Janssen-Cilaq Merck Sharp & Dohme and consultancy fees from Janssen -Cilag, ViiV Healthcare and Merck Sharp & Dohme. The other authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
